Induction immunosuppression after heart transplantation: Monoclonal vs. polyclonal antithymoglobulins. Is there a difference?

Interactive Cardiovascular and Thoracic Surgery

Volumn 4, Issue 5, 2005, Pages 415-419

  Haddad, Michel ^a,b   Alghofaili, Fahad S ^a   Fergusson, Dean A ^b   Masters, Roy G ^b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Heart transplantation; Immunosuppression; Monoclonal; Polyclonal; Thymoglobulin

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MONOCLONAL ANTIBODY; OKT 3; POLYCLONAL ANTIBODY; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; CARDIAC GRAFT REJECTION; CLINICAL TRIAL; DATA ANALYSIS; FEVER; GRAFT INFECTION; HEADACHE; HEART TRANSPLANTATION; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; LUNG EDEMA; META ANALYSIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; SURVIVAL; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 30744432103     PISSN: 15699293     EISSN: 15699293     Source Type: Journal    
DOI: 10.1510/icvts.2004.105262     Document Type: Review

References (15)

1. Kormos RL, Armitage JM, Dummer JS, Miyamoto Y, Griffith BP, Hardesty RL. Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin. Transplantation 1990;49(2):306-311.
2. Kobashigawa JA, Stevenson LW, Brownfield E, Moriguchi JD, Kawata N, Hamilton M, Minkely R, Drinkwater D, Laks H. Does short-course induction with OKT3 improve outcome after heart transplantation? A randomized trial. J Heart Lung Transplant 1993;12:250-258.
3. Kormos RL, Herlan DB, Armitage JM, Stein K, Kaufman C, Zeevi A, Duquesnoy R, Herdesty RL, Griffith BP. Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation. J Heart Lung Transplant 1990;9:1-10.
4. Costanzo-Nordin MR, O'Sullivan EJ, Johnson MR, Winters GL, Pifarre R, Radvany R, Zucker MJ, Scanlon PJ, Robinson JA. Prospective randomized trial of OKT3 vs. horse antithymocyte globulin-based immuno-suppressive prophylaxis in heart transplantation. J Heart Transplantation 1990;9(3 pt 2):306-315.
5. Renlund DG, O'Connell JB, Gilbert EM, Hammond ME, Burton NA, Jones KW, Karwande SV, Doty DB, Menlove RL, Herrick CM, Lee HR, Gay WA, Bristow MR. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3. Transplantation 1989;47(4):599-605.
6. Griffith BP, Kormos RL, Armitage JM, Dummer JS, Hardesty RL. Comparative trial of immunoprophylaxis with RATG vs. OKT3. J Heart Transplant 1990;9(3 pt 2):301-305.
7. MacDonald PS, Mundy J, Keogh AM, Chang VP, Spratt PM. A prospective randomized study of prophylactic OKT3 vs. equine antithymocyte globulin after heart transplantation increased morbidity with OKT3. Transplantation 1993;55(1):110-116.
8. Menkis AH, Powell AM, Novick RJ, McKenzie FN, Kostuk WJ, Pflugfelder PW, Brown JE, Rochon J, Chow LH, Stiller C. A prospective randomized controlled trial of initial immunosuppression with ALG vs. OKT3 in recipients of cardiac allografts. J Heart Lung Transplantation 1992;11(3 pt 1):569-576.
9. Ippoliti G, Negri M, Abelli P, Rovati B, Di Franco L, Grossi P, Minoli L, Ascari E, Vigano M. Preoperative prophylactic OKT3 vs. RATG. A randomized clinical study in heart transplantation. Transplantation Proceedings 1991;23(4):2272-2274.
10. Laske A, Gallino A, Schneider J, Bauer EP, Carrel T, Pasic M, Von Segesser LK, Turina MI. Prophylactic cytolytic therapy in heart transplantation: Monoclonal vs. polyclonal antibody therapy. J Heart Lung Transplantation 1992;11:557-563.
11. Kirklin JK, Bourge RC, White-Williams C, Naftel DC, Thomas FT, Thomas JM, Phillips MG. Prophylactic therapy for rejection after cardiac transplantation: a comparison of rabbit antithymocyte globulin and OKT3. J Thorac Cardiovasc Surg 1990;99:716-724.
12. Ladowski JS, Dollon T, Schatzlein MH, Peterson AC, Deschner WP, Beatty L, Sullivan M, Scheeringa RH, Clark WR. Prophylaxis of heart transplant rejection with either antithymocyte globulin-Minnesota antilymphocyte globulin-, or an OKT3-based protocol. J Cardiovasc Surg (Torino) 1993;34(2):135-140.
13. Balk AH, Meeter K, Simoons ML, Brouwer RM, Zondervan PE, Mochtar B, Bos E, Weimar W. Polyclonal vs. monoclonal rejection prophylaxis after heart transplantation: a randomized study. Transplant International 1992;5(supp 1):S476-S479.
14. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. Brit Med J 1994;309:1286-1291.
15. Jadad AR, Moore RA, Carrol D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.